Gómez EO

Idioma: Español
Referencias bibliográficas: 8
Paginas: 482
Archivo PDF: 57.76 Kb.

FRAGMENTO

Objetivo: comparar los efectos terapéuticos de fluoxetina y placebo en el tratamiento de dolor y estreñimiento en síndrome de intestino irritable (SII).

REFERENCIAS (EN ESTE ARTÍCULO)

1. Schoenfeld P. Efficacy of current drug therapies in irritable bowel syndrome: What works and does not work. Gastroenterol Clin N Am 2005; 34: 319-35.

2. O’Malley PG, Jackson JL, Santoro J, et al. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Pract 1999; 48: 980-90.

3. Jackson J, O’Malley P, Tomkins G, et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000; 108: 65-72.

4. Creed F, Fernandes L, Guthrie E, et al. The cost-effectiveness of psycotherapy and paroxetine for severe irritable bowel syndrome. Gastroenterology 2003; 124: 30317

5. Talley NJ. New and emerging treatments for irritable bowel syndrome and functional dyspepsia. Expert Opin Emerg Drugs 2002; 7: 91-8.

6. Gram L. Fluoxetine. N Engl J Med 1994; 331: 1354-61.

7. Kuiken SD, Tytgat GN, Boeckxstaens GE. The selective serotonin inhibitor fluoxetine does not change rectal sensitivity and symptoms in patients with irritable bowel syndrome: a double blind, randomized, placebo-controlled study. Clin Gastroenterol Hepatol 2003; 1: 219-28.

8. Aranth J, Lindberg C. Bleeding, a side effect of fluoxetine. Am J Psychiatry 1992; 149: 412.